Key result
In treated hypertensive patients with ECG-LVH, baseline LBBB was associated with a higher likelihood of developing new segmental LV wall motion abnormalities at 3 years.
Why the study?
It was unknown whether left bundle branch block is related to new-onset left ventricular wall motion abnormalities during treatment in hypertensive patients with ECG-defined left ventricular hypertrophy.
Does the presence of LBBB predict the development of new-onset abnormal LV wall motion in treated hypertensive patients with ECG-LVH?
Cohort (n=784)
Does the presence of LBBB predict the development of new-onset abnormal LV wall motion in treated hypertensive patients with ECG-LVH?
Answers are grounded in this paper and cite their sources.
In hypertensive patients with ECG-LVH, baseline LBBB is an independent predictor of developing new segmental LV wall motion abnormalities, suggesting it may be a marker for progressive myocardial disease.
AIMS: We aimed to investigate whether left bundle branch block (LBBB) is related to new-onset left ventricle (LV) wall motion abnormalities during treatment in hypertensive patients with electrocardiographic (ECG) defined left ventricular hypertrophy (LVH). METHODS AND RESULTS: 960 patients with essential hypertension and ECG-LVH participating in the LIFE Echo Sub-study were investigated at baseline and annually with echocardiography, during randomized antihypertensive therapy. After excluding patients with LV wall motion abnormalities at baseline and patients developing new-onset LBBB during study time, we investigated 784 patients. The participants with (n = 32) and without (n = 752) LBBB were similar regarding most baseline variables. Logistic regression models controlling for LV mass index, Framingham risk score, and randomized treatment assignment were used to assess the odds ratio of developing new-onset abnormal LV wall motion on annual follow-up echocardiograms. The likelihood of developing new global LV wall motion abnormalities in patients with LBBB was not higher compared to those without LBBB except at year 5 (p = .002). The likelihood of developing new segmental LV wall motion abnormalities in patients with LBBB was however higher compared to patients without LBBB after 1 year (OR = 3.1, 95% CI = 0.7-14.2, p = .173); 2 years (OR = 6.9, 2.1-22.4, p = .003); 3 years (OR = 5.3, 2.0-14.3, p < .001), 4 years (OR = 4.0, 1.6-10.3, p = .003 and 5 years (OR = 4.1, 1.0-16.2, p = .394) of treatment. CONCLUSION: Among patients with ECG-LVH, undergoing antihypertensive treatment, the presence of LBBB independently identifies individuals with ∼3- to 7-fold greater odds of developing new segmental abnormal LV wall motion. These findings suggest that LBBB may be a marker for progressive myocardial disease.
No takes yet. Share an insight, caveat, or question.
Stokke et al. (2019) conducted a cohort in essential hypertension and ECG-LVH (n=784). Left bundle branch block (LBBB) vs. No LBBB was evaluated on New segmental LV wall motion abnormalities at 3 years (OR 5.3, 95% CI 2.0-14.3, p=<.001). In treated hypertensive patients with ECG-LVH, baseline LBBB was associated with a higher likelihood of developing new segmental LV wall motion abnormalities at 3 years.
Synapse has enriched 10 related papers. Consider them for comparative context: